Prostalund AB (FRA:7PL0) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7PL0 Prostalund AB FRA:7PL0
10 GF Score
Price €0.00
GF Value €0.02
! 6 Warning Signs
View Full Analysis

What is Prostalund AB Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:7PL0
10GF Score
Prostalund AB FRA:7PL0
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Prostalund AB (FRA:7PL0) Overvalued in 2026?

Based on GuruFocus' analysis, Prostalund AB stock appears to be undervalued. The current stock price of €0.00 is trading 97.5% below its estimated GF Value™ of €0.02.

Key valuation signals for FRA:7PL0:

  • Short Ratio:
  • GF Value™: €0.02 vs. price of €0.00 (97.5% below fair value)
  • GF Score™: 10/100 with 6 warning signs

No single metric tells the full story. See the FRA:7PL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prostalund AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 63
Prostalund AB develops, markets and sells urological products. The Company has a treatment concept (CoreTherm Concept) for personalized heat treatment for the condition benign prostatic hyperplasia, also known as BPH or BPE, which mainly affects men over the age of 50. It has developed a new platform, CoreTherm Eagle which includes an inbuilt computer, real-time temperature reading, patient data storage and inbuilt recommendations for treating physicians.
10GF Score

Get the complete analysis for FRA:7PL0

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price
€0.02
GF Value